From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage by Connolly et al. transfusionevidencelibrary.com/alerts/article…

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024: #MetaAnalysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure by Martens et al. transfusionevidencelibrary.com/alerts/article…

From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Prehospital #tranexamicacid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials by Mazzei et al. transfusionevidencelibrary.com/alerts/article…

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024: Two-year outcomes following a randomised platelet transfusion trial in preterm infants by Moore et al. transfusionevidencelibrary.com/alerts/article…

From the #Transfusion Evidence Round-Up Best of the TEL 2024: Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands (...) by Ree et al transfusionevidencelibrary.com/alerts/article…

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024: Early Cold Stored Platelet Transfusion Following Severe Injury: A Randomized Clinical Trial by Sperry et al. transfusionevidencelibrary.com/articles/38708…

New from #StemCellEvidence: Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation by Abboud et al. stemcellevidence.com/alerts/article…

From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury by Turgeon et al. transfusionevidencelibrary.com/alerts/article…

Thank you ISBT Central Office volunteers and staff and SRI - Systematic Review Initiative for all your hard work with the Transfusion Evidence Round-Ups during 2024!

From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury by Turgeon et al. transfusionevidencelibrary.com/alerts/article…

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024: A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial by Williams et al. transfusionevidencelibrary.com/alerts/article…

From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Efficacy and safety of #tranexamicacid in acute traumatic brain injury: A #metaanalysis of randomized controlled trials by Zhang and Liu transfusionevidencelibrary.com/articles/38502…

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024: A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial by Williams et al. transfusionevidencelibrary.com/alerts/article…

From the #Transfusion Evidence Round-Up: Best of the TEL 2024: Efficacy and safety of #tranexamicacid in acute traumatic brain injury: A #metaanalysis of randomized controlled trials by Zhang and Liu transfusionevidencelibrary.com/articles/38502…

New from #StemCellEvidence: Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia by Gui et al. stemcellevidence.com/alerts/article…

There is an urgent need for blood - especially O negative and B negative blood types. We are calling on blood donors to book an appointment to donate as soon as possible. There are 11,000 appointment slots that need to be filled to help save lives. ➡️ orlo.uk/9mFRt

From the #StemCellEvidence Alert: Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease by Mahmoudjafari et al. stemcellevidence.com/alerts/article…

New from #StemCellEvidence: Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis by Meyer et al. stemcellevidence.com/alerts/article…

An exciting new post is available that offers the opportunity to become a Locum Consultant Haematologist with an interest in Advanced Cellular Therapeutics. You will be a key member of both NHS Blood and Transplant (NHSBT) and Bedfordshire Hospitals NHS Foundation Trust teams.

No time like the present 📅 Thousands of people across #NorthernIreland need donated blood to help them overcome, or live well, with cancer or various other illnesses 🩸❤️ Please give blood 🙏 Book now at bit.ly/GiveBloodNI #GiveBlood #SaveLives #BloodDonation #Lifesaver